companydata.dkcompanydata.dk

Frederiksstaden Pharma ApS: Financial statements 2022

CVR: 25630483

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Frederiksstaden Pharma ApS (CVR 25630483) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 13,098 and a net result of DKK 3,759 compared with DKK -1,410,402 the year before. Equity in the 2022 report amounted to DKK 230,981. The solvency ratio was 87.6%.

Gross Profit
DKK 13,098
Profit/Loss
DKK 3,759
Equity
DKK 230,981
Total Assets
DKK 263,824
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-13 t.4 t.231 t.0
2021--666 t.-1.4 mio.227 t.3
2020-2 mio.-1.8 mio.1.6 mio.7
2019-1.4 mio.-3.3 mio.-2.2 mio.-
2018-2.2 mio.-6.2 mio.1.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Frederiksstaden Pharma ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Mohammad Sohail Asghar leaves the board of Frederiksstaden Pharma ApSMay 5, 2022

As of May 5, 2022, Mohammad Sohail Asghar has left the board of directors of Frederiksstaden Pharma ApS.

Søren Wang Petersen leaves the board of Frederiksstaden Pharma ApSMay 5, 2022

As of May 5, 2022, Søren Wang Petersen has left the board of directors of Frederiksstaden Pharma ApS.

Rolf Eckersberg leaves the board of Frederiksstaden Pharma ApSMay 5, 2022

As of May 5, 2022, Rolf Eckersberg has left the board of directors of Frederiksstaden Pharma ApS.

Jens-Nikolaj Schøier leaves the board of Frederiksstaden Pharma ApSMay 5, 2022

As of May 5, 2022, Jens-Nikolaj Schøier has left the board of directors of Frederiksstaden Pharma ApS.

Jens-Nikolaj Schøier joins Frederiksstaden Pharma ApS as directorMay 5, 2022

As of May 5, 2022, Jens-Nikolaj Schøier is registered as director of Frederiksstaden Pharma ApS.

Rolf Eckersberg steps down as director of Frederiksstaden Pharma ApSMay 5, 2022

As of May 5, 2022, Rolf Eckersberg has stepped down as director of Frederiksstaden Pharma ApS.

NPPHorsholm ApS changes name to Frederiksstaden Pharma ApSMay 5, 2022

On May 5, 2022, the company changed its name from NPPHorsholm ApS to Frederiksstaden Pharma ApS.

XGX Pharma ApS registered as owner of Frederiksstaden Pharma ApSApr 27, 2022

As of April 27, 2022, XGX Pharma ApS is registered as an owner of Frederiksstaden Pharma ApS with an ownership share of 100%.

Frederiksstaden Pharma ApS: The 2021 annual report is outApr 21, 2022

Frederiksstaden Pharma ApS has published its annual report for 2021. Gross profit came to DKK -666,382, and the net result was DKK -1,410,402.

About Frederiksstaden Pharma ApS

Frederiksstaden Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2000. The company is registered under the industry Pakkeriaktiviteter. The company was previously named NPPHorsholm ApS and Nord Pharma Partners ApS. The management consists of Jens-Nikolaj Schøier. The company is owned by XGX Pharma ApS. The company has 2 employees (2021). In 2025, the company reported a gross profit of DKK 61,605 and a net result of DKK 139,819 compared with DKK -50,518 the year before. Equity in the 2025 report amounted to DKK 237,986.

Source: annual report 2025, Danish Business Authority